BACKGROUND: A growing body of research points towards a substantial number of prostate cancer patients experiencing distress and anxiety. This study examines the frequency and character of cancer- and treatment-related problems and its association with symptom distress and prostate cancer-related anxiety in patients at the beginning of an oncological rehabilitation program. PATIENTS AND METHODS: 197 prostate cancer patients who had undergone prostatectomy (92.5% participation rate) completed the Memorial Anxiety Scale for Prostate Cancer (MAX-PC), the NCCN Distress Thermometer and EORTC QLQ-C30 subscales emotional function and global quality of life. RESULTS: 88% of patients report cancer- or treatment-related problems with a mean of 5 problems, and 104 patients (53%) experience distress and/or prostate cancer-related anxiety. The most prevalent symptoms are changes in urination, sexual problems, difficulties getting around, pain, fatigue and sleep problems. Emotional problems such as nervousness, worries, fears and sadness are prevalent in at least 53% of patients. Patients with distress and anxiety are confronted with a higher number and a wider range of problems and experience significantly lower levels of quality of life. CONCLUSION: Findings emphasize the role of cancer rehabilitation and underline the importance of psychosocial screening measures and the provision of psychosocial support in prostate cancer patients.
BACKGROUND: A growing body of research points towards a substantial number of prostate cancerpatients experiencing distress and anxiety. This study examines the frequency and character of cancer- and treatment-related problems and its association with symptom distress and prostate cancer-related anxiety in patients at the beginning of an oncological rehabilitation program. PATIENTS AND METHODS: 197 prostate cancerpatients who had undergone prostatectomy (92.5% participation rate) completed the Memorial Anxiety Scale for Prostate Cancer (MAX-PC), the NCCN Distress Thermometer and EORTC QLQ-C30 subscales emotional function and global quality of life. RESULTS: 88% of patients report cancer- or treatment-related problems with a mean of 5 problems, and 104 patients (53%) experience distress and/or prostate cancer-related anxiety. The most prevalent symptoms are changes in urination, sexual problems, difficulties getting around, pain, fatigue and sleep problems. Emotional problems such as nervousness, worries, fears and sadness are prevalent in at least 53% of patients. Patients with distress and anxiety are confronted with a higher number and a wider range of problems and experience significantly lower levels of quality of life. CONCLUSION: Findings emphasize the role of cancer rehabilitation and underline the importance of psychosocial screening measures and the provision of psychosocial support in prostate cancerpatients.
Authors: Terry A Badger; Chris Segrin; Aurelio J Figueredo; Joanne Harrington; Kate Sheppard; Stacey Passalacqua; Alice Pasvogel; Maria Bishop Journal: Qual Life Res Date: 2010-12-19 Impact factor: 4.147
Authors: Valentin H Meissner; Kathleen Herkommer; Birgitt Marten-Mittag; Jürgen E Gschwend; Andreas Dinkel Journal: J Cancer Surviv Date: 2017-05-21 Impact factor: 4.442
Authors: Roderick C N van den Bergh; Ida J Korfage; Gerard J J M Borsboom; Ewout W Steyerberg; Marie-Louise Essink-Bot Journal: Qual Life Res Date: 2009-08-09 Impact factor: 4.147
Authors: N Ernstmann; M Neumann; O Ommen; M Galushko; M Wirtz; R Voltz; M Hallek; H Pfaff Journal: Support Care Cancer Date: 2009-03-13 Impact factor: 3.603
Authors: Karly M Murphy; Christina Sauer; Dershung Yang; Niina Hass; Kristian Novakovic; Brian Helfand; Robert Nadler; Benjamin D Schalet; David Victorson Journal: Cancer Nurs Date: 2022 Jan-Feb 01 Impact factor: 2.592